Total Clarity Wealth Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Total Clarity Wealth Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$7K	–	1050
2022 Q2	$7K	Buy	+300	New	+$6.61K	﹤0.01%	763
2022 Q1	–	Sell	-800	Closed	-$29K	–	993
2021 Q4	$29K	Buy	+800	New	+$28.1K	0.01%	495

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Total Clarity Wealth Management's CCXI Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 300 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in CCXI in Q4 2021 and held it in 2 quarters. The position peaked at $29K in Q4 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Total Clarity Wealth Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 300 ChemoCentryx, Inc. shares in Q3 2022, an estimated $7K.
Total Clarity Wealth Management first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 2 quarters.
Total Clarity Wealth Management's ChemoCentryx, Inc. position peaked at $29K in Q4 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.